Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...

Estimated 440 deaths reported from Jan. 5 to Feb. 1, 2025, with minimal impact on results when excluding certain causes of death.

In the US, the CDC recommends shingles vaccination for all adults aged 50 and older. However, uptake has been low, partly due to limited awareness, cost concerns, and missed opportunities during ...

Children receiving mepolizumab have increased expression of gene modules linked to epithelial and macrophage inflammatory pathways.